Facebook
Twitter
LinkedIn
Forward
Emerging Topics in Liver Disease Conference: Innovative Trends in Liver Health 2024
In-Person and Virtual attendance options are available.
Presented by the Sherrie and Alan Conover Center for Liver Disease & Transplantation at Houston Methodist
The epidemic of liver disease has become increasingly more common and poses complex problems regarding diagnosis and management. There are recent advances in the diagnosis and management of patients with liver disease. This CE activity has been designed to educate attendees about new developments in hepatology, and new approaches to management of liver diseases that can be readily integrated into their daily practice. A group of national experts, including several renowned guest faculty, will present new findings in a clinical context that will be beneficial in the multidisciplinary management of unique and complex liver disorders.
This course, in addition to lecture format presentations, will provide interactive instructional presentations, debate and panel discussions, Q&A sessions, case discussions and use an interactive audience response system
.FEES
| REGISTRATION TYPE | FEE |
|---|---|
| Physician (Houston Methodist) | $25 |
| Physician (Private physician located within the Greater Houston Area)* | $300 |
| Physician (Private physician located outside the Greater Houston Area) | $50 |
| Allied Health Care Professional (including Nurses) | $10 |
| Resident / Fellow / Student | Complimentary |
* In compliance with HM’s policy on Physician Non-Monetary Compensation regarding “Stark Law,” private physicians who reside and/or practice medicine within the Greater Houston Area are required to pay the full Fair Market Value registration fee.
Target Audience
This conference is designed for primary care physicians, internists, hepatologists, gastroenterologists, oncologists, nurses, nurse practitioners, and physician assistants and other health care providers.
Learning Objectives
At the conclusion of this activity, the participant should be able to:
- Discuss the current trends in Liver Disease.
- Describe new and critical developments in chronic HBV, HCV and HDV.
- Identify emerging trends in the obesity crisis & nonalcoholic fatty liver disease and explore the latest concepts in diagnosis and management.
- Discuss new developments and treatment of liver and pancreatic cancers – an emerging epidemic.
| Emerging Topics in Liver Disease Conference | ||
| AGENDA | Saturday, September 21 | ||
| TIME | PRESENTATION | SPEAKER(S) |
| 7:00 AM | Registration and Breakfast | |
| 7:30 AM | Welcome | Victor Ankoma-Sey, MD |
| 7:35 AM | Introductory Remarks | R. Mark Ghobrial, MD, PhD, FACS, FRCS (Ed) |
| PLENARY SESSION I Alcoholic Liver Disease - An Update Moderators: Joseph Galati, MD, Chukwuma Egwim, MD & Ashish Saharia, MD | ||
| 7:40 AM | Alcohol Use Disorder and Alcohol Associated Liver Disease - Evolving Definitions, Diagnosis & Epidemiology | Ashwani K. Singal, MD |
| 8:10 AM | State of the Art Lecture I Alcohol Associated Liver Disease: Current & Future Therapies | Ramon Bataller, MD |
| 8:40 AM | Alcohol Associated Liver Disease & Liver Transplantation | R. Mark Ghobrial, MD, PhD, FACS, FRCS (Ed) |
| 9:05 AM | Q&A and Discussion | |
| 9:20 AM | BREAK | |
| PLENARY SESSION II Current Innovations in the Management of Unique Liver Diseases Moderators: Dr. Tamneet Basra , Caroline Simon, MD, Andres Duchini, MD | ||
| 9:35 AM | State of the Art Lecture II Genetic Liver Diseases in adults (Hemochromatosis, Wilson’s, Alpha-1-antitrypsin deficiency): What do we know in 2024? | Michael Schilsky, MD |
| 10:05 AM | Drug induced Liver Injury- an Update | David E. Bernstein, MD |
| 10:35 AM | Chronic Viral Hepatitis B: Can we expect a Cure? | W. Ray Kim, MD |
| 11:05 AM | Chronic Viral Hepatitis C Elimination: Obstacles & Opportunities | Norah A. Terrault, MD |
| 11:35 AM | Q&A and Discussion | |
| 11:50 AM | LUNCH & PRODUCT THEATRE MASLD: An Overview | Mazen Nourreddin, MD, MHSc |
| PLENARY SESSION III Metabolic Dysfunction-Associated Fatty liver Disease (MASLD)- What is New ? Moderators: Victor Ankoma-Sey, MD, David Victor, MD & Constance Mobley, MD | ||
| 12:50 PM | Metabolic Dysfunction-Associated Fatty liver Disease (MASLD): The New Nomenclature and its implications | Mary Rinella, MD |
| 1:20 PM | Practical Use of Noninvasive Tests in the Diagnosis & Management of MASLD patients | Naim Alkhouri, MD, FAASLD |
| 1:50 PM | State of the Art Lecture III Current and Future Treatment Options in MASLD | TBD |
| 2:20 PM | Role of Artificial Intelligence (AI) in the Management of MASLD? | Vlad Ratziu, MD |
| 2:50 PM | Q&A and Discussion | |
| 3:05 PM | BREAK | |
| PLENARY SESSION IV Liver Cancers: Hepatocellular Carcinoma & Cholangiocarcinoma - Current Concepts & Controversies Moderators: Sudha Kodali, MD, MSPH, Maen Abdelrahim, MD, PhD, B Pharm & Kirk Heyne, MD | ||
| 3:20 PM | Evolving Epidemiology of Hepatocellular Cancer & Cholangiocarcinoma? | Amit Singal, MD |
| 3:50 PM | State of the Art Lecture IV Management of Hepatocellular carcinoma & Cholangiocarcinoma - Role of immunotherapy & Ablative Therapies | Ahmed Kaseb, MD |
| 4:20 PM | Liver Transplantation for Hepatocellular Cancer & Cholangiocarcinoma – Current Approach & Controversies | Sudha Kodali, MD |
| 4:45 PM | Q&A and Discussion | |
| 5:00 PM | CONCLUDING REMARKS | |
In-Person attendance will be held in the Houston Methodist Research Institute (6670 Bertner Avenue, Houston, Texas 77030).
Virtual information will be provided to registered learners.
| COURSE DIRECTOR |
| Victor Ankoma-Sey, MD, FACP, FAASLD |
| Director, Liver Transplant Program Sherrie and Alan Conover Center for Liver Disease & Transplantation Houston Methodist J.C. Walter Jr. Transplant Center Director, Liver Associates of Texas, PA |
Available Credit
- 7.75 AMA PRA Category 1 Credit™
Houston Methodist is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Houston Methodist designates this Live activity for a maximum of 7.75 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
- 7.75 Attendance
- 8.00 Nursing Contact Hours
Houston Methodist is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.
Houston Methodist will award 8.00 Nursing Continuing Professional Development contact hours for this activity. Participants must attend the activity in its entirety and complete the continuing education evaluation.
- 7.75 Transplant CoordinatorsThe American Board for Transplant Certification (ABTC) has assigned the following Continuing Education Points for Transplant Certification (CEPTCs) to the following Houston Methodist Transplant Center educational program: Emerging Topics in Liver Disease Conference: Innovative Trends in Liver Health 2024 | Sun, 05/26/2024 - 8:00am | 7.75 Category 1 CEPTCs
Interested in exhibiting? Contact us for more information.
Price
REGISTRATION INSTRUCTIONS
- STEP 1 - Choose the activity format you would like to attend (LIVE or LIVESTREAM) by selecting the checkbox next to the activity and clicking the "Enroll" button.
- STEP 2 - Once enrolled, click the link of the activity format for which you enrolled (the Status should say "In progress") and then click the "Take Course" button to begin the activity.
FEES
| REGISTRATION TYPE | FEE |
|---|---|
| Physician (Houston Methodist) | $25 |
| Physician (Private physician located within the Greater Houston Area)* | $300 |
| Physician (Private physician located outside the Greater Houston Area) | $50 |
| Allied Health Care Professional (including Nurses) | $10 |
| Resident / Fellow / Student | Complimentary |
* In compliance with HM’s policy on Physician Non-Monetary Compensation regarding “Stark Law,” private physicians who reside and/or practice medicine within the Greater Houston Area are required to pay the full Fair Market Value registration fee.